ARTICLE | Clinical News
Cerovive: Phase III ongoing
October 18, 2004 7:00 AM UTC
An independent data monitoring committee recommended continuation of the SAINT I and SAINT II Phase III trials. AZN licensed the compound from Centaur Pharmaceuticals Inc., which RNVS acquired in 200...